This compound is primarily used in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the creation of various drug candidates, especially those targeting neurological and psychiatric disorders. Its structure, featuring both bromine and fluorine substituents, allows for precise modifications in drug design, enhancing binding affinity and selectivity to specific biological targets. Additionally, it is utilized in the preparation of compounds for preclinical studies, aiding in the exploration of new therapeutic agents. Its role in medicinal chemistry is significant due to its potential to improve drug efficacy and safety profiles.